Horowitz, Michael

Effect of hyperglycemia on triggering of transient lower esophageal sphincter relaxations

Zhang, Q., Horowitz, M., Rigda, R., Rayner, C., Worynski, A., & Holloway, R. H. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Gastroesophageal reflux and treatmentsGastrointestinal motility and disorders

Cited by 30

Gastrointestinal adverse events with insulin glargine/lixisenatide fixed‐ratio combination versus glucagon‐like peptide‐1 receptor agonist s in people with type 2 diabetes mellitus: A network meta‐analysis

Rayner, C. K., Wu, T., Aroda, V. R., Whittington, C., Kanters, S., Guyot, P., Shaunik, A., & Horowitz, M. (2021) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 23

Accurate Measurements of Gastric Emptying and Gastrointestinal Symptoms in the Evaluation of Glucagon-like Peptide-1 Receptor Agonists

Jalleh, R. J., Jones, K. L., Nauck, M., & Horowitz, M. (2023) · Annals of Internal Medicine

Gastrointestinal motility and disordersDiabetes Treatment and Management

Cited by 18

Glucose sensing mediated by portal glucagon-like peptide 1 receptor is markedly impaired in insulin-resistant obese animals

Malbert, C.-H., Chauvin, A., Horowitz, M., & Jones, K. L. (2021) · Diabetes

Diabetes Treatment and ManagementRegulation of Appetite and Obesity

Cited by 18

Non-peptide, once-per-day oral orforglipron to compete with established peptide-based, injectable GLP-1 receptor agonists

Nauck, M. A., & Horowitz, M. (2023) · The Lancet

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 16

Longitudinal evaluation of gastric emptying in type 2 diabetes

Watson, L. E., Phillips, L. K., Wu, T., Bound, M. J., Jones, K. L., Horowitz, M., & Rayner, C. K. (2019) · Diabetes Research and Clinical Practice

Gastrointestinal motility and disordersDiabetes Treatment and Management

Cited by 13